Structure of a single-chain Fv fragment of an antibody that inhibits the HIV-1 and HIV-2 proteases

被引:2
|
作者
Lescar, J
Brynda, J
Fabry, M
Horejsi, M
Rezacova, P
Sedlacek, J
Bentley, GA
机构
[1] Inst Pasteur, Dept Biol Struct & Chim, Unite Immunol Struct, CNRS,URA 2185, F-75724 Paris 15, France
[2] European Synchrotron Radiat Facil, F-38043 Grenoble, France
[3] Acad Sci Czech Republ, Inst Mol Genet, Dept Gene Manipulat, CR-16637 Prague 6, Czech Republic
来源
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY | 2003年 / 59卷
关键词
D O I
10.1107/S0907444903003597
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The monoclonal antibody 1696, which was raised against the HIV-1 protease, inhibits the catalytic activity of the enzyme from both the HIV-1 and HIV-2 strains. The antibody cross-reacts with peptides containing the N-terminus of the enzyme, which is highly conserved between these strains. The crystal structure of a single-chain Fv fragment of 1696 ( scFv-1696) in the non-complexed form, solved at 1.7 Angstrom resolution, is compared with the previously reported non-complexed Fab-1696 and antigen-bound scFv-1696 structures. Large conformational changes in the third hypervariable region of the heavy chain and differences in relative orientation of the variable domains are observed between the different structures.
引用
收藏
页码:955 / 957
页数:3
相关论文
共 50 条
  • [31] REGULATION OF AUTOPROTEOLYSIS OF THE HIV-1 AND HIV-2 PROTEASES WITH ENGINEERED AMINO-ACID SUBSTITUTIONS
    ROSE, JR
    SALTO, R
    CRAIK, CS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (16) : 11939 - 11945
  • [32] Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment
    Arndt, KM
    Müller, KM
    Plückthun, A
    BIOCHEMISTRY, 1998, 37 (37) : 12918 - 12926
  • [33] Latex Agglutination Test Based on Single-Chain Fv Recombinant Antibody Fragment
    Golchin, M.
    Khalili-Yazdi, A.
    Karamouzian, M.
    Abareghi, A.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2012, 75 (01) : 38 - 45
  • [34] Thermal stabilization of a single-chain Fv antibody fragment by introduction of a disulphide bond
    Young, NM
    MacKenzie, CR
    Narang, SA
    Oomen, RP
    Baenziger, JE
    FEBS LETTERS, 1995, 377 (02) : 135 - 139
  • [35] Development of functional human monoclonal single-chain variable fragment antibody against HIV-1 from human cervical B cells
    Berry, JD
    Rutherford, J
    Silverman, GJ
    Kaul, R
    Elia, M
    Gobuty, S
    Fuller, R
    Plummer, FA
    Barbas, CF
    HYBRIDOMA AND HYBRIDOMICS, 2003, 22 (02): : 97 - 108
  • [36] Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia
    van der Loeff, MFS
    Jaffar, S
    Aveika, AA
    Sabally, S
    Corrah, T
    Harding, E
    Alabi, A
    Bayang, A
    Ariyoshi, K
    Whittle, HC
    AIDS, 2002, 16 (13) : 1775 - 1783
  • [37] An HIV-1/HIV-2 Chimeric Envelope Glycoprotein Generates Binding and Neutralising Antibodies against HIV-1 and HIV-2 Isolates
    Taveira, Nuno
    Figueiredo, Ines
    Calado, Rita
    Martin, Francisco
    Bartolo, Ines
    Marcelino, Jose M.
    Borrego, Pedro
    Cardoso, Fernando
    Barroso, Helena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [38] Importance of an Early HIV Antibody Differentiation Immunoassay for Detection of Dual Infection with HIV-1 and HIV-2
    Zbinden, Andrea
    Durig, Roland
    Shah, Cyril
    Boni, Jurg
    Schupbach, Jorg
    PLOS ONE, 2016, 11 (06):
  • [39] Exploration of the effect of sequence variations located inside the binding pocket of HIV-1 and HIV-2 proteases
    Triki, Dhoha
    Billot, Telli
    Visseaux, Benoit
    Descamps, Diane
    Flatters, Delphine
    Camproux, Anne-Claude
    Regad, Leslie
    SCIENTIFIC REPORTS, 2018, 8
  • [40] HIV subtype detectability, HIV-1 seroconversion sensitivity and HIV-2 dilutional sensitivity by an automated HIV-1/HIV-2 chemiluminescent immunoassay.
    Edwin, C
    Barin, F
    Camacho, R
    Valle, H
    Kanki, P
    Fang, C
    Baker, L
    Tirrell, S
    CLINICAL CHEMISTRY, 1998, 44 : A4 - A4